NEWS Life Molecular Imaging announces presentation of new scientific data at the Alzheimer’s Association International Conference 14 July 2023 LEARN MORE
NEWS Life Molecular Imaging Applauds FDA’s Full Approval of LEQEMBI® for Alzheimer’s Disease 6 July 2023 LEARN MORE
NEWS Life Molecular Imaging Announces Start of Phase 3 Study with [18F]Florbetaben in Cardiac Amyloid Light Chain (AL) Amyloidosis 7 February 2023 LEARN MORE
NEWS Life Molecular Imaging and Advanced Medical Support Announce a Strategic Partnership for the Production of Florbetaben (18F) at the American University of Beirut Medical Centre, Lebanon 25 January 2023 LEARN MORE
NEWS Life Molecular Imaging Announces Start of the Phase 3 Histopathology Study “ADvance” for the Tau PET Tracer [18F]PI-2620 17 January 2023 LEARN MORE
NEWS Life Molecular Imaging and Jubilant Radiopharma announce Neuraceq® availability in Southeast United States 10 January 2023 LEARN MORE
NEWS Life Molecular Imaging announces presentation of new scientific data at the European Association of Nuclear Medicine annual meeting 2022 14 October 2022 LEARN MORE
NEWS Statement of Life Molecular Imaging on Eisai and Biogen announcing Positive Topline Results of their Phase 3 Clarity AD Study 28 September 2022 LEARN MORE
NEWS Life Molecular Imaging and Curium Pharma Announce the Start of Neuraceq® Production at Curium’s Blackrock Clinic in Dublin 29 August 2022 LEARN MORE
